- Home
- HOFT vs OTLK Comparison
HOFT vs OTLK Comparison
Compare HOFT & OTLK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HOFT | OTLK |
|---|---|---|
| Founded | 1924 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Home Furnishings | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 115.9M | 119.6M |
| IPO Year | 1999 | 2016 |
Fundamental Metrics
Financial Performance| Metric | HOFT | OTLK |
|---|---|---|
| Price | $11.18 | $1.59 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $4.67 |
| AVG Volume (30 Days) | 45.8K | ★ 4.2M |
| Earning Date | 12-11-2025 | 02-13-2026 |
| Dividend Yield | ★ 4.07% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $375,494,000.00 | $1,413,535.00 |
| Revenue This Year | N/A | $2,048.59 |
| Revenue Next Year | $9.02 | $142.11 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 13.82 | N/A |
| 52 Week Low | $7.34 | $0.79 |
| 52 Week High | $14.23 | $3.39 |
Technical Indicators
Market Signals| Indicator | HOFT | OTLK |
|---|---|---|
| Relative Strength Index (RSI) | 56.46 | 39.72 |
| Support Level | $10.78 | $1.78 |
| Resistance Level | $11.36 | $2.03 |
| Average True Range (ATR) | 0.65 | 0.25 |
| MACD | -0.01 | -0.07 |
| Stochastic Oscillator | 80.42 | 6.39 |
Price Performance
Historical ComparisonAbout HOFT Hooker Furnishings Corporation
Hooker Furnishings Corp is a designer, marketer and importer of casegoods (wooden and metal furniture), leather furniture, fabric-upholstered furniture, lighting, accessories, and home decor for the residential, hospitality and contract markets. It is also domestically manufactured premium residential custom leather, custom fabric-upholstered furniture, and outdoor furniture. The company operates in four segment Hooker Branded segment, Home Meridian segment, Domestic Upholstery segment and All Other.
About OTLK Outlook Therapeutics Inc.
Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. The Company have received marketing authorization for an ophthalmic formulation of ONS-5010/LYTENAVA (bevacizumab-gamma) for use in treating wet age-related macular degeneration, or wet AMD, in the European Union, and United Kingdom. The product pipeline includes ONS-5010/LYTENAVA, which is in total eight NORSES; ONS-5010 Clinical Progress, Unmet Patient Needs, New Ophthalmic Anti-VEGF, and Potential First Line Therapy.